Abstract
B- and T-lymphocyte attenuator (BTLA) is an immune-regulatory receptor, similar to CTLA-4 and PD-1, and is mainly expressed on B-, T-, and all mature lymphocyte cells. Herpes virus entry mediator (HVEM)-BTLA plays a critical role in immune tolerance and immune responses which are areas of intense research. However, the mechanisms of the BTLA and the BTLA/HVEM signaling pathway in human diseases remain unclear. This review describes the research milestones of BTLA and HVEM in chronological order and their role in chronic HBV infection.
Author supplied keywords
Cite
CITATION STYLE
Yu, X., Zheng, Y., Mao, R., Su, Z., & Zhang, J. (2019). BTLA/HVEM signaling: Milestones in research and role in chronic hepatitis B virus infection. Frontiers in Immunology. Frontiers Media S.A. https://doi.org/10.3389/fimmu.2019.00617
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.